GLP-1 compounder issues recall for copycat Zepbound
The notice adds to growing concerns about the safety of knockoff weight loss drugs, which have remained popular despite FDA warnings and legal pressure from Eli Lilly and Novo.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.